Article: Sunlight Research(TM), Releases Its Amgen EPO Patents Report.

Report to be provided on a Complimentary basis at the Intellectual Property Owners Association Annual Meeting in Chicago, September 13-15, 2009

MINNEAPOLIS and CHICAGO, Sept. 14 /PRNewswire/ -- Sunlight Research(TM) - The Source for Patent Analysis (http://www.sunlightresearch.com/) today announced the release of its report analyzing Amgen, Inc.'s Erythropoietin (EPO) US patent portfolio.

The Report analyzes the patent claims coverage of 38 US patents owned or controlled by Amgen , and explains how those patents do or do not cover the corresponding technology used in their commercial product Epogen. The technology focuses on recombinant erythropoietin, ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!